Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gilchrist

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
Physical Therapy|January 17, 2009
A framework for assessment in oncology rehabilitationLaura S Gilchrist, Mary Lou Galantino, Meredith Wampler, et al.
Mayo Clinic Proceedings|February 1, 1985
Trends and variability in survival among patients with osteosarcoma: a 7-year updateW F Taylor, J C Ivins, D J Pritchard, et al.
Journal of Geriatric Physical Therapy (2001)|September 23, 2011
Balance interventions for diabetic peripheral neuropathy: a systematic reviewKatherine I Ites, Elizabeth J Anderson, Megan L Cahill, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Transfer factor versus combination chemotherapy: a preliminary report of a randomized postsurgical adjuvant treatment study in osteogenic sarcomaJ C Ivins, R E Ritts, D J Pritchard, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1984
Sequential half-body irradiation (SHBI) and combination chemotherapy as salvage treatment for failed Ewing's sarcoma--a pilot studyR G Evans, E O Burgert, G S Gilchrist, et al.
Cancer Treatment Reports|February 1, 1978
Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapyG S Gilchrist, J C Ivins, R E Ritts, et al.
Oncology|January 1, 1981
High-dose methotrexate with a safe rescue programD A Decker, J H Edmonson, G S Gilchrist, et al.
National Cancer Institute Monograph|April 1, 1981
Management of osteogenic sarcoma: a perspective based on the Mayo Clinic experienceG S Gilchrist, D J Pritchard, D C Dahlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammationYubin Li, Mousa Komai-Koma, Derek S Gilchrist, et al.
Mayo Clinic Proceedings|September 1, 1975
Intra-abdominal, angiofollicular lymph node hyperplasia (plasma-cell variant) with an antierythropoietic factorE O Burgert, G S Gilchrist, V F Fairbanks, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
Physical Therapy|January 17, 2009
A framework for assessment in oncology rehabilitationLaura S Gilchrist, Mary Lou Galantino, Meredith Wampler, et al.
Mayo Clinic Proceedings|February 1, 1985
Trends and variability in survival among patients with osteosarcoma: a 7-year updateW F Taylor, J C Ivins, D J Pritchard, et al.
Journal of Geriatric Physical Therapy (2001)|September 23, 2011
Balance interventions for diabetic peripheral neuropathy: a systematic reviewKatherine I Ites, Elizabeth J Anderson, Megan L Cahill, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Transfer factor versus combination chemotherapy: a preliminary report of a randomized postsurgical adjuvant treatment study in osteogenic sarcomaJ C Ivins, R E Ritts, D J Pritchard, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1984
Sequential half-body irradiation (SHBI) and combination chemotherapy as salvage treatment for failed Ewing's sarcoma--a pilot studyR G Evans, E O Burgert, G S Gilchrist, et al.
Cancer Treatment Reports|February 1, 1978
Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapyG S Gilchrist, J C Ivins, R E Ritts, et al.
Oncology|January 1, 1981
High-dose methotrexate with a safe rescue programD A Decker, J H Edmonson, G S Gilchrist, et al.
National Cancer Institute Monograph|April 1, 1981
Management of osteogenic sarcoma: a perspective based on the Mayo Clinic experienceG S Gilchrist, D J Pritchard, D C Dahlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammationYubin Li, Mousa Komai-Koma, Derek S Gilchrist, et al.
Mayo Clinic Proceedings|September 1, 1975
Intra-abdominal, angiofollicular lymph node hyperplasia (plasma-cell variant) with an antierythropoietic factorE O Burgert, G S Gilchrist, V F Fairbanks, et al.
Pageof 23